Latest News: Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity baseZydus Healthcare appoints Swati Dalal MDNatco Pharma appoints Yarramshetty Krishna Rao as Senior Vice President – Operations at MekagudaNatco API plant gets one observation from FDAPharma department refuses to name 30 doctors in bribery tangleDelhi Police busts fake cancer drugs racketSun Pharma appoints Kirti Ganorkar as the Managing DirectorPune Horror: Pharma sudent killed on way home by unlicensed driverBee might have bared Fangs like Death for Karishma Kapoor’s Ex HubbySale of scheduled drugs through online portal, IndiaMART, curbed: T.N. policeTwo die, one critical after a gas leak at Pharma CityDCA raids medical shop in Hyderabad, illegal medicines worth Rs 25K seizedPharma firm Captab Biotech banned in Punjab for 3 years following adverse drug reactionsFUJIFILM resolves to detect Breast Cancer early with Apollo HospitalsDabur reaches out to distributors as quick commerce disrupts general tradeKerala Launches MedWatch App to Verify Medicine AuthenticityPilani Public School begins in VizagRaids in Cuttack med shops over illegal sale of abortion kitsDoctors trialling ‘poo pills’ to flush out dangerous superbugsThe idea of Modern Medtech Park in Delhi germinatesCadila launches beta-blocker Biscado for treatment of cardiovascular diseasesAMTZ moves to build ‘Device’ to rate Buildings on Accessibility QuotientEye stroke alert: Ozempic linked to rare vision-loss conditionGlenmark to launch cancer drug Zanubrutinib in IndiaDrug smuggling racket busted inside Ropar jail; ASI, head constable, among others arrestedNepal ex-PM under fire for alleged corruption over Patanjali-linked land deal, fined $1 millionNCB seizes Rs 9.2 crore assets of ‘prime accused’ in transnational drugs trafficking case from NoidaWockhardt’s novel antibiotic Zaynich eyes $9 billion global marketFake cosmetics racket busted in Bhubaneswar’s Unit-1 MarketIllegally stocked drugs worth Rs 5.21 lakh seizedPatanjali and AIIMS Bhopal partner to develop holistic treatment solutionsNPPA fixes retail prices for 41 drug combinations, including empagliflozinDrug Inspector Dismissed After Rs 4 Crore Cash Found in Sacks; Linked to Illegal Sale of Pharmacist DegreesDelhi Crime branch cracks down on fake cancer drug sellers, arrest six individuals‘Made in India’ Surgical Robot SSI Mantra’s Hallowed NASDAQ Moment in New YorkZydus to acquire 2 biologics manufacturing units in U.S. from Agenus for $125 millionAnanda Pharma advances CBD drug with Phase 1 study listingWith Advent of Level Playing Field, Domestic MedTech Industry exclaims ‘Eureka!’Govt supports indigenous manufacturing of complex pharma excipients by Nitika Pharmaceutical SpecialtiesMedical representatives barred from govt hospitals to stop pharma influenceGeneric drugs can bring hope for SMA patients’47% of pharma MOUs from VGGS 2024 commissionedI-Sec downgrades Aurobindo Pharma to Add, target price Rs 1,330AstraZeneca gets CDSCO nod for lung cancer drugAnar Modi named CHO at Senores PharmaNatco Pharma Q4 Results: Profit Misses Estimates, Margin Contracts; FY26 Outlook GloomyCops bust inter-state pharma drug cartel, nab 51,787 abortion kits seized, 6 FIRs filed after raids in Haryana last weekStock market update: Nifty Pharma index advances 0.11%Amrut Medhekar to exit Akums Drugs and Pharma as CEO-CDMO BusinessRamping Up Community for JeevanRaksha during DisastersAbsconding for years, mastermind behind inter-state illegal drug syndicate lands in police netThree Day IGHM fame Healthcare Conclave proved Mahakumbh of Who’s WhoSun Pharma to invest $25 million in Pharmazz Inc; raises stake to 22.7%Divis Lab enters into a LT manufacturing and supply agreement with a global pharma co.Alembic Pharma receives USFDA nod for Amlodipine and Atorvastatin TabletsFake cosmetic makers raided across Gujarat, products worth ₹1 crore seizedLincoln Pharma posts Rs 11.62 cr profit for Jan-Mar; revenue at Rs 161 crFDA panel debates COVID-19 vaccine recipe as questions swirl about fall shotsBharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol55 drugs manufactured in Himachal found not of standard quality42 cos banned over supply of substandard drugsGland Pharma Q4 results: Profit dips 3% YoY to ₹187 crore; 1800% dividend announcedMedical shop operating without licence raided, illegal stock seizedZydus Wellness posts 30% profit growth in FY25, Q4 net sales up 17% YoYLupin to boost complex generics in US, EU; eyes chronic growth in IndiaGrowth Triggers Line Up for Divi’s LabsFrom generic drugs to vaccines, Indian pharma industry is transforming lives worldwideIndia’s pharma sector ranks third in worldPU files patents for green nanoplatform in skincare and pharmaSingapore May Avoid US Pharma Tariffs: Deputy PMFire disrupts production at GSK Pharma’s contract manufacturing siteTrump targets Big Pharma with drug price order; Indian generics seen gaining edgeEmcutix and Mantra Pharma Introduce Ureaderm: Advanced Urea-Based Moisturizers for Indian SkinDCA seizes syrup stocks over misleading fever cure claimMankind Pharma Faces Rs 341.86 Cr Tax DemandPiramal Pharma stock falls 5% after Q4 results; check key numbers hereBiolumpivaxin: Bharat Biotech launches new vaccine against lumpy skin diseaseDTAB asks DCGI to take up withdrawal of license for certain FDC antibiotics with SLAsIndia’s anti-obesity drug market quadruples in five years on lifestyle disease surge3 held with 60,000 tramadol tabletsIndian Pharma May See Limited Short-Term Impact from US Drug Pricing OrderHip Hip No Hurray: Steroid Misuse Linked To Rising Damage In YouthsAntibiotic use in infancy raises early puberty risk in girls, study findsFIR against three chemists for illegal sale of abortion kits in GurgaonPharma sector continues to thrive, driven by price-led expansionTPG to acquire 35% stake in SCHOTT Poonawalla from SIIIndian pharma industry showed impressive growth in April 2025, by price led expansion: ReportDiabetes drug shows promise for treating prostate cancerBiocon Q4 net profit surges 153%, biosimilars, generics drive growthIndia puts in place a health emergency plan for Jammu and Kashmir, transports portable hospitals to Poonch, UriCEO speaks: India’s AI-Powered Pharma Revolution: The Next Big Wave in HealthcareSuven Pharmaceuticals renamed as Cohance LifesciencesDabur misses estimates, profit drops 8% to Rs 320 croreRussian govt to take additional measures to avoid drug shortagesNeutral Alembic Pharma; target of Rs 930: Motilal OswalTrump’s new executive orders may hit Indian Pharma exports, reshape global drug supply chains: ReportDCGI Greenlights Akums’ Extended-Release NVP Tablet: A First for India’s Pharma SectorTatva Chintan Pharma slides as Q4 PAT drops 89% YoY to Rs 1 crPanel to take a call on doorstep medicine delivery
Tue. Jun 17th, 2025
Latest News: Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity baseZydus Healthcare appoints Swati Dalal MDNatco Pharma appoints Yarramshetty Krishna Rao as Senior Vice President – Operations at MekagudaNatco API plant gets one observation from FDAPharma department refuses to name 30 doctors in bribery tangleDelhi Police busts fake cancer drugs racketSun Pharma appoints Kirti Ganorkar as the Managing DirectorPune Horror: Pharma sudent killed on way home by unlicensed driverBee might have bared Fangs like Death for Karishma Kapoor’s Ex HubbySale of scheduled drugs through online portal, IndiaMART, curbed: T.N. policeTwo die, one critical after a gas leak at Pharma CityDCA raids medical shop in Hyderabad, illegal medicines worth Rs 25K seizedPharma firm Captab Biotech banned in Punjab for 3 years following adverse drug reactionsFUJIFILM resolves to detect Breast Cancer early with Apollo HospitalsDabur reaches out to distributors as quick commerce disrupts general tradeKerala Launches MedWatch App to Verify Medicine AuthenticityPilani Public School begins in VizagRaids in Cuttack med shops over illegal sale of abortion kitsDoctors trialling ‘poo pills’ to flush out dangerous superbugsThe idea of Modern Medtech Park in Delhi germinatesCadila launches beta-blocker Biscado for treatment of cardiovascular diseasesAMTZ moves to build ‘Device’ to rate Buildings on Accessibility QuotientEye stroke alert: Ozempic linked to rare vision-loss conditionGlenmark to launch cancer drug Zanubrutinib in IndiaDrug smuggling racket busted inside Ropar jail; ASI, head constable, among others arrestedNepal ex-PM under fire for alleged corruption over Patanjali-linked land deal, fined $1 millionNCB seizes Rs 9.2 crore assets of ‘prime accused’ in transnational drugs trafficking case from NoidaWockhardt’s novel antibiotic Zaynich eyes $9 billion global marketFake cosmetics racket busted in Bhubaneswar’s Unit-1 MarketIllegally stocked drugs worth Rs 5.21 lakh seizedPatanjali and AIIMS Bhopal partner to develop holistic treatment solutionsNPPA fixes retail prices for 41 drug combinations, including empagliflozinDrug Inspector Dismissed After Rs 4 Crore Cash Found in Sacks; Linked to Illegal Sale of Pharmacist DegreesDelhi Crime branch cracks down on fake cancer drug sellers, arrest six individuals‘Made in India’ Surgical Robot SSI Mantra’s Hallowed NASDAQ Moment in New YorkZydus to acquire 2 biologics manufacturing units in U.S. from Agenus for $125 millionAnanda Pharma advances CBD drug with Phase 1 study listingWith Advent of Level Playing Field, Domestic MedTech Industry exclaims ‘Eureka!’Govt supports indigenous manufacturing of complex pharma excipients by Nitika Pharmaceutical SpecialtiesMedical representatives barred from govt hospitals to stop pharma influenceGeneric drugs can bring hope for SMA patients’47% of pharma MOUs from VGGS 2024 commissionedI-Sec downgrades Aurobindo Pharma to Add, target price Rs 1,330AstraZeneca gets CDSCO nod for lung cancer drugAnar Modi named CHO at Senores PharmaNatco Pharma Q4 Results: Profit Misses Estimates, Margin Contracts; FY26 Outlook GloomyCops bust inter-state pharma drug cartel, nab 51,787 abortion kits seized, 6 FIRs filed after raids in Haryana last weekStock market update: Nifty Pharma index advances 0.11%Amrut Medhekar to exit Akums Drugs and Pharma as CEO-CDMO BusinessRamping Up Community for JeevanRaksha during DisastersAbsconding for years, mastermind behind inter-state illegal drug syndicate lands in police netThree Day IGHM fame Healthcare Conclave proved Mahakumbh of Who’s WhoSun Pharma to invest $25 million in Pharmazz Inc; raises stake to 22.7%Divis Lab enters into a LT manufacturing and supply agreement with a global pharma co.Alembic Pharma receives USFDA nod for Amlodipine and Atorvastatin TabletsFake cosmetic makers raided across Gujarat, products worth ₹1 crore seizedLincoln Pharma posts Rs 11.62 cr profit for Jan-Mar; revenue at Rs 161 crFDA panel debates COVID-19 vaccine recipe as questions swirl about fall shotsBharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol55 drugs manufactured in Himachal found not of standard quality42 cos banned over supply of substandard drugsGland Pharma Q4 results: Profit dips 3% YoY to ₹187 crore; 1800% dividend announcedMedical shop operating without licence raided, illegal stock seizedZydus Wellness posts 30% profit growth in FY25, Q4 net sales up 17% YoYLupin to boost complex generics in US, EU; eyes chronic growth in IndiaGrowth Triggers Line Up for Divi’s LabsFrom generic drugs to vaccines, Indian pharma industry is transforming lives worldwideIndia’s pharma sector ranks third in worldPU files patents for green nanoplatform in skincare and pharmaSingapore May Avoid US Pharma Tariffs: Deputy PMFire disrupts production at GSK Pharma’s contract manufacturing siteTrump targets Big Pharma with drug price order; Indian generics seen gaining edgeEmcutix and Mantra Pharma Introduce Ureaderm: Advanced Urea-Based Moisturizers for Indian SkinDCA seizes syrup stocks over misleading fever cure claimMankind Pharma Faces Rs 341.86 Cr Tax DemandPiramal Pharma stock falls 5% after Q4 results; check key numbers hereBiolumpivaxin: Bharat Biotech launches new vaccine against lumpy skin diseaseDTAB asks DCGI to take up withdrawal of license for certain FDC antibiotics with SLAsIndia’s anti-obesity drug market quadruples in five years on lifestyle disease surge3 held with 60,000 tramadol tabletsIndian Pharma May See Limited Short-Term Impact from US Drug Pricing OrderHip Hip No Hurray: Steroid Misuse Linked To Rising Damage In YouthsAntibiotic use in infancy raises early puberty risk in girls, study findsFIR against three chemists for illegal sale of abortion kits in GurgaonPharma sector continues to thrive, driven by price-led expansionTPG to acquire 35% stake in SCHOTT Poonawalla from SIIIndian pharma industry showed impressive growth in April 2025, by price led expansion: ReportDiabetes drug shows promise for treating prostate cancerBiocon Q4 net profit surges 153%, biosimilars, generics drive growthIndia puts in place a health emergency plan for Jammu and Kashmir, transports portable hospitals to Poonch, UriCEO speaks: India’s AI-Powered Pharma Revolution: The Next Big Wave in HealthcareSuven Pharmaceuticals renamed as Cohance LifesciencesDabur misses estimates, profit drops 8% to Rs 320 croreRussian govt to take additional measures to avoid drug shortagesNeutral Alembic Pharma; target of Rs 930: Motilal OswalTrump’s new executive orders may hit Indian Pharma exports, reshape global drug supply chains: ReportDCGI Greenlights Akums’ Extended-Release NVP Tablet: A First for India’s Pharma SectorTatva Chintan Pharma slides as Q4 PAT drops 89% YoY to Rs 1 crPanel to take a call on doorstep medicine delivery
Tue. Jun 17th, 2025

Natco Pharma seeks USFDA approval for hepatitis drug

New Delhi: Drug firm Natco Pharma today said it has filed an abbreviated new drug application (ANDA) for Sofosbuvir Tablets, 400mg, with the United States Food and Drug Administration (USFDA).

Sofosbuvir is used for chronic hepatitis C infection and sold globally by Gilead Sciences, Inc, under its brand Sovaldi, Natco Pharma said in a filing to BSE.

The company believes that “they are the first to have filed a substantially complete ANDA containing a Paragraph IV certification for this product and expects to be eligible for 180 days of marketing exclusivity upon receiving final FDA approval,” it added.

For the 12 months ending December 31, 2017, Sovaldi had US sales of approximately USD 130 million as per Gilead Sciences Inc’s unaudited results released for the year ending December 31, 2017, Natco Pharma said.

Shares of Natco Pharma were trading at Rs 786.05 per scrip on BSE, down 1.65 per cent from its previous close.

    • admin

    Related Posts

    Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base
    • Pharma
    • June 17, 2025
    • 66 views
    Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base

    Bengaluru-based biopharmaceutical firm Biocon on Monday launched a qualified institutions placement (QIP) to raise Rs 4,500 crore. As part of the offering, the firm will issue up to 139 million…

    Continue reading
    Zydus Healthcare appoints Swati Dalal MD
    • Pharma
    • June 17, 2025
    • 78 views
    Zydus Healthcare appoints Swati Dalal MD

    Zydus Lifesciences Ltd on Monday announced the appointment of Swati Dalal as an additional director and Managing Director of its wholly-owned arm Zydus Healthcare Ltd. The board of Zydus Healthcare…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base

    Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base

    Zydus Healthcare appoints Swati Dalal MD

    Zydus Healthcare appoints Swati Dalal MD

    Natco Pharma appoints Yarramshetty Krishna Rao as Senior Vice President – Operations at Mekaguda

    Natco Pharma appoints Yarramshetty Krishna Rao as Senior Vice President – Operations at Mekaguda

    Natco API plant gets one observation from FDA

    Natco API plant gets one observation from FDA